Table 4.
Variable 1 ESRD | C Statistic 1 | SE 1 | 95% CI | Variable 2 | C Statistic 2 | SE 2 | 95% CI | r | P |
---|---|---|---|---|---|---|---|---|---|
ACR0 | 0.920 | 0.011 | 0.898–0.942 | ACR−1 | 0.895 | 0.012 | 0.872–0.919 | 0.81 | <0.001 |
ACR0 | 0.920 | 0.011 | 0.898–0.942 | Covariates | 0.839 | 0.015 | 0.810–0.868 | 0.51 | <0.001 |
ACR0 | 0.920 | 0.011 | 0.898–0.942 | ACR−1 + ACR0 | 0.920 | 0.011 | 0.898–0.942 | 0.99 | 0.4 |
ACR−1 | 0.895 | 0.012 | 0.872–0.919 | Covariates | 0.839 | 0.015 | 0.810–0.868 | 0.70 | <0.001 |
ACR−1 | 0.895 | 0.012 | 0.872–0.919 | ACR−1 + ACR0 | 0.920 | 0.011 | 0.898–0.942 | 0.81 | <0.001 |
Covariates | 0.839 | 0.015 | 0.810–0.868 | ACR−1 + ACR0 | 0.920 | 0.011 | 0.898–0.942 | 0.51 | <0.001 |
Natural mortality | |||||||||
ACR0 | 0.812 | 0.015 | 0.783–0.841 | ACR−1 | 0.810 | 0.015 | 0.781–0.839 | 0.97 | 0.8 |
ACR0 | 0.812 | 0.015 | 0.783–0.841 | Covariates | 0.800 | 0.015 | 0.771–0.829 | 0.90 | 0.1 |
ACR0 | 0.812 | 0.015 | 0.783–0.841 | ACR−1 + ACR0 | 0.812 | 0.015 | 0.783–0.841 | 0.99 | 0.1 |
ACR−1 | 0.810 | 0.015 | 0.781–0.839 | Covariates | 0.800 | 0.015 | 0.771–0.829 | 0.94 | 0.06 |
ACR−1 | 0.810 | 0.015 | 0.781–0.839 | ACR−1 + ACR0 | 0.812 | 0.015 | 0.783–0.841 | 0.97 | 0.6 |
Covariates | 0.800 | 0.015 | 0.771–0.829 | ACR−1 + ACR0 | 0.812 | 0.015 | 0.783–0.841 | 0.90 | 0.08 |
Note: Covariates included sex, baseline age, diabetes duration, and antihypertensive medication. P refers to pairwise comparison between c statistic 1 and c statistic 2, and r is correlation between the 2 statistics introduced by studying the same sample of people.
Abbreviations: ESRD, end-stage renal disease; ACR0, second ACR measurement; ACR−1, first ACR measurement; ACR, albumin-creatinine ratio.